Chenqi Guo

425 total citations · 1 hit paper
17 papers, 304 citations indexed

About

Chenqi Guo is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Chenqi Guo has authored 17 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomedical Engineering, 6 papers in Biomaterials and 5 papers in Molecular Biology. Recurrent topics in Chenqi Guo's work include Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Pharmacological Effects of Natural Compounds (3 papers). Chenqi Guo is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Pharmacological Effects of Natural Compounds (3 papers). Chenqi Guo collaborates with scholars based in China, United States and South Korea. Chenqi Guo's co-authors include Peihong Xiao, Ben Zhong Tang, Yi Wu, Wei Xie, Zipeng Shen, Qian Wu, Fubing Wang, Dong Wang, Jianyu Zhang and Tao Gong and has published in prestigious journals such as Journal of the American Chemical Society, ACS Nano and Chemical Communications.

In The Last Decade

Chenqi Guo

14 papers receiving 299 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nano drug delivery systems for advanced immune checkpoint blockade therapy

2025 52 citations Chenqi Guo, Ling Lin et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chenqi Guo China	9	189	110	91	68	61	17	304
Zimeng Yang China	9	97 0.5×	66 0.6×	112 1.2×	108 1.6×	42 0.7×	25	333
Zhenhuan Song China	10	300 1.6×	183 1.7×	140 1.5×	135 2.0×	87 1.4×	12	537
Yinnong Jia China	11	75 0.4×	110 1.0×	100 1.1×	50 0.7×	37 0.6×	21	346
Maolin Jiang China	12	239 1.3×	85 0.8×	126 1.4×	127 1.9×	33 0.5×	22	352
Zhimin Mo China	10	300 1.6×	188 1.7×	90 1.0×	108 1.6×	87 1.4×	14	437
Kai Deng China	12	278 1.5×	120 1.1×	124 1.4×	125 1.8×	112 1.8×	30	467
Qingqing Huang China	12	101 0.5×	44 0.4×	162 1.8×	83 1.2×	49 0.8×	32	347
Binglin Ye China	8	176 0.9×	99 0.9×	121 1.3×	67 1.0×	40 0.7×	13	390
Elise Bouffard France	9	240 1.3×	189 1.7×	97 1.1×	58 0.9×	107 1.8×	12	343
Shuangshuang Ji China	8	343 1.8×	262 2.4×	92 1.0×	74 1.1×	121 2.0×	16	468

Countries citing papers authored by Chenqi Guo

Since Specialization

Citations

This map shows the geographic impact of Chenqi Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenqi Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenqi Guo more than expected).

Fields of papers citing papers by Chenqi Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenqi Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenqi Guo. The network helps show where Chenqi Guo may publish in the future.

Co-authorship network of co-authors of Chenqi Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chenqi Guo. A scholar is included among the top collaborators of Chenqi Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenqi Guo. Chenqi Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Guo, Chenqi, Ling Lin, Yihan Wang, et al.. (2025). Nano drug delivery systems for advanced immune checkpoint blockade therapy. Theranostics. 15(11). 5440–5480. 52 indexed citations breakdown →

Guo, Chenqi, Junchen Li, Yingdong Wang, et al.. (2024). Efficacy and safety of compound glycyrrhizin combined with topical minoxidil for alopecia areata: a systematic review and meta-analysis of randomized controlled trials. Journal of Dermatological Treatment. 35(1). 2381766–2381766.

Wu, Mengying, Wei Zhang, Sha Li, et al.. (2024). An in situ forming gel co-loaded with pirarubicin and celecoxib inhibits postoperative recurrence and metastasis of breast cancer. International Journal of Pharmaceutics. 653. 123897–123897. 1 indexed citations

Zhang, Wei, Mengying Wu, Chenqi Guo, et al.. (2024). Dual-Targeting Macrophages and Hepatic Stellate Cells by Modified Albumin Nanoparticles for Liver Cirrhosis Treatment. ACS Applied Materials & Interfaces. 16(9). 11239–11250. 5 indexed citations

Yang, Qin, et al.. (2023). Combined Amphiphilic Silybin Meglumine Nanosuspension Effective Against Hepatic Fibrosis in Mice Model. International Journal of Nanomedicine. Volume 18. 5197–5211. 12 indexed citations

Zhang, Jianfeng, Yingdong Wang, Lin Peng, et al.. (2023). Efficacy and safety of Runzao Zhiyang capsule for chronic urticaria: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology. 14. 1200252–1200252.

Yang, Yuping, et al.. (2023). A sustained-release phospholipid-based phase separation gel loaded with berberine for treating rheumatoid arthritis. Frontiers in Pharmacology. 14. 1210129–1210129. 5 indexed citations

Guo, Chenqi, Mengying Wu, Zhaofei Guo, et al.. (2023). Hypoxia-Responsive Golgi-Targeted Prodrug Assembled with Anthracycline for Improved Antitumor and Antimetastasis Efficacy. ACS Nano. 17(24). 24972–24987. 17 indexed citations

Xiao, Peihong, Wei Xie, Jianyu Zhang, et al.. (2022). De Novo Design of Reversibly pH-Switchable NIR-II Aggregation-Induced Emission Luminogens for Efficient Phototheranostics of Patient-Derived Tumor Xenografts. Journal of the American Chemical Society. 145(1). 334–344. 134 indexed citations

10.

Yang, Qin, Qin He, Chenqi Guo, et al.. (2022). Silybin Meglumine-Stabilized Nanosuspension Enhances the Therapeutic Efficacy of Silybin Against Hepatic Fibrosis. SSRN Electronic Journal.

11.

Guo, Chenqi, Ting Zhao, Zhaofei Guo, et al.. (2022). Albumin-based multidrug delivery system enriched in Golgi apparatus against metastatic breast cancer. Nano Research. 16(4). 5640–5652. 5 indexed citations

12.

Zhou, Hongli, Dan Chen, Ting Gong, et al.. (2021). Chlorogenic acid sustained-release gel for treatment of glioma and hepatocellular carcinoma. European Journal of Pharmaceutics and Biopharmaceutics. 166. 103–110. 9 indexed citations

13.

Zhao, Ting, Lei Lei, Chenqi Guo, et al.. (2020). A new tandem peptide modified liposomal doxorubicin for tumor “ecological therapy”. Nanoscale. 12(5). 3359–3369. 18 indexed citations

14.

Zhang, Anke, Houshi Xu, Chenqi Guo, et al.. (2020). Diabetes mellitus contributes to carbamazepine resistance in patient with trigeminal neuralgia. Neurosurgical Review. 44(2). 1119–1125. 1 indexed citations

15.

Song, Xu, Chenqi Guo, Juan Zhao, et al.. (2019). Alternative and Injectable Preformed Albumin-Bound Anticancer Drug Delivery System for Anticancer and Antimetastasis Treatment. ACS Applied Materials & Interfaces. 11(45). 42534–42548. 20 indexed citations

16.

Yang, Qin, Tiantian Tan, Juan Zhao, et al.. (2019). A reversible decomposition approach for the formation of injectable, excipient-free, self-assembling nanocrystals. Chemical Communications. 55(21). 3144–3147. 8 indexed citations

17.

Guo, Chenqi, Wenhao Li, Juan Zhao, et al.. (2018). A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies. Drug Development and Industrial Pharmacy. 44(12). 2005–2012. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact